Aligned Genetics, Inc. · KRX:238120

Aligned Genetics, Inc. financial statements

Aligned Genetics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue16.0B15.8B15.2B13.8B11.8B7.96B7.79B5.68B5.64B4.71B
Cost of revenue4.79B4.62B4.54B4.99B4.42B3.41B3.18B2.32B2.04B2.19B
Gross profit11.2B11.2B10.7B8.77B7.35B4.54B4.61B3.36B3.60B2.52B
Research and development2.02B2.29B1.68B1.08B943.6M816.2M884.8M1.16B940.4M578.1M
Selling, general and administrative2.12B5.72B5.22B4.36B3.86B3.51B3.66B3.91B4.06B3.43B
Operating income2.44B2.78B3.34B2.85B2.18B-253.5M-398.9M-1.92B-1.85B-1.67B
Depreciation and amortization609.0M548.1M596.2M650.4M538.6M676.1M716.4M487.4M419.5M136.4M
EBITDA3.05B3.33B3.93B3.50B2.72B422.6M317.4M-1.44B-1.43B-1.54B
Interest expense103.9M169.1M214.9M166.0M28.9M82.8M118.6M000
Income before tax2.65B4.54B3.42B2.44B3.81B468.2M116.7M-1.59B-1.75B-1.56B
Income tax109.5M-1.73B
Net income2.91B4.13B3.24B2.33B5.54B468.2M116.7M-1.59B-1.75B-1.56B
Earnings per share, basic207.10287.09225.05162.23385.4065.1316.24-220.89-244.02-218.38

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents14.6B8.33B14.9B9.44B5.28B5.64B4.90B2.87B7.41B9.31B
Short-term investments7.88B03.00B7.00B6.50B9.00B4.05B12.1B12.3B
Receivables2.62B2.89B2.67B1.45B2.13B1.27B1.16B1.22B1.24B966.4M
Inventory4.98B4.20B3.85B3.76B2.35B2.11B2.12B2.15B1.36B1.71B
Current assets22.8B25.6B21.6B19.6B18.4B15.9B17.3B17.4B22.3B24.4B
Property, plant and equipment7.77B8.04B7.29B5.78B1.67B2.04B675.8M670.0M450.8M
Total assets57.8B44.3B40.9B36.9B34.5B25.5B24.6B23.0B24.3B25.9B
Accounts payable153.7M97.5M164.9M134.3M144.5M278.4M157.4M72.5M41.8M83.0M
Current liabilities4.49B1.90B5.24B1.33B1.42B1.22B901.2M701.1M596.2M651.1M
Long-term debt11.8B2.40B03.90B3.90B
Total debt916.8M994.0M
Total liabilities20.6B8.78B9.62B8.05B7.48B4.02B3.65B2.11B1.67B1.68B
Shareholders' equity37.2B35.5B31.3B28.8B27.0B21.5B21.0B20.9B22.6B24.2B
Shares outstanding14.1M14.4M14.4M14.4M14.4M7.19M7.19M7.19M7.19M7.12M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations3.61B3.07B2.85B2.22B136.0M35.7M659.3M-1.75B-876.7M-1.14B
Capital spending-12.9B-340.1M-880.4M-2.00B-3.31B-96.4M-261.6M-213.4M-405.4M-864.9M
Free cash flow-9.30B2.66B1.97B218.8M-4.73B-69.8M133.5M-1.96B-1.28B-2.01B
Cash from investing-7.55B1.29B2.54B-3.67B1.17B1.53B-2.92B-1.08B-12.8B
Cash from financing-1.73B-192.8M-176.3M3.63B-227.6M-203.8M-203.8M164.3M20.0B
Share buybacks-997.5M0164.3M20.0B
Change in cash4.48B-4.79B4.23B4.56B498.3M740.8M2.03B-4.54B-1.90B6.07B